{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T07:17:00Z","timestamp":1792653420878,"version":"4.5.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,10,30]],"date-time":"2012-10-30T00:00:00Z","timestamp":1351555200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagn Pathol"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1186\/1746-1596-7-149","type":"journal-article","created":{"date-parts":[[2012,10,31]],"date-time":"2012-10-31T17:17:54Z","timestamp":1351703874000},"source":"Crossref","is-referenced-by-count":102,"title":["The diagnostic value of arginase-1 immunostaining in differentiating hepatocellular carcinoma from metastatic carcinoma and cholangiocarcinoma as compared to HepPar-1"],"prefix":"10.1186","volume":"7","author":[{"given":"Nehal A","family":"Radwan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naglaa S","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,10,30]]},"reference":[{"key":"620_CR1","first-page":"421673","volume":"2012","author":"S Waly Raphael","year":"2012","unstructured":"Waly Raphael S, Yangde Z, Yuxiang C: Hepatocellular carcinoma: focus on different aspects of management. ISRN Oncol. 2012, 2012: 421673-","journal-title":"ISRN Oncol"},{"issue":"1\u20132","key":"620_CR2","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.mrrev.2008.01.005","volume":"659","author":"WA Anwar","year":"2008","unstructured":"Anwar WA, Khaled HM, Amra HA, El-Nezami H, Loffredo CA: Changing pattern of hepatocellular carcinoma (HCC) and its risk factors in Egypt: possibilities for prevention. Mutat Res. 2008, 659 (1\u20132): 176-184.","journal-title":"Mutat Res"},{"issue":"3","key":"620_CR3","doi-asserted-by":"crossref","first-page":"704","DOI":"10.3892\/ol.2011.546","volume":"3","author":"E Aleem","year":"2012","unstructured":"Aleem E, Elshayeb A, Elhabachi N, Mansour AR, Gowily A, Hela A: Serum IGFBP-3 is a more effective predictor than IGF-1 and IGF-2 for the development of hepatocellular carcinoma in patients with chronic HCV infection. Oncol Lett. 2012, 3 (3): 704-712.","journal-title":"Oncol Lett"},{"issue":"1","key":"620_CR4","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1097\/00125480-200301000-00004","volume":"10","author":"LW Lamps","year":"2003","unstructured":"Lamps LW, Folpe AL: The diagnostic value of hepatocyte paraffin antibody 1 in differentiating hepatocellular neoplasms from nonhepatic tumors: a review. Adv Anat Pathol. 2003, 10 (1): 39-43. 10.1097\/00125480-200301000-00004.","journal-title":"Adv Anat Pathol"},{"issue":"4","key":"620_CR5","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1002\/cncy.21190","volume":"120","author":"M Fujiwara","year":"2012","unstructured":"Fujiwara M, Kwok S, Yano H, Pai RK: Arginase-1 is a more sensitive marker of hepatic differentiation than HepPar-1 and glypican-3 in fine-needle aspiration biopsies. Cancer Cytopathol. 2012, 120 (4): 230-237. 10.1002\/cncy.21190.","journal-title":"Cancer Cytopathol"},{"issue":"8","key":"620_CR6","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1097\/PAS.0b013e3181e5dffa","volume":"34","author":"BC Yan","year":"2010","unstructured":"Yan BC, Gong C, Song J, Krausz T, Tretiakova M, Hyjek E, Al-Ahmadie H, Alves V, Xiao SY, Anders RA, Hart JA: Arginase-1: a new immunohistochemical marker of hepatocytes and hepatocellular neoplasms. Am J Surg Pathol. 2010, 34 (8): 1147-1154. 10.1097\/PAS.0b013e3181e5dffa.","journal-title":"Am J Surg Pathol"},{"key":"620_CR7","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.5858\/2007-131-1648-BPIDIH","volume":"131","author":"S Kakar","year":"2007","unstructured":"Kakar S, Gown AM, Goodman ZD, Ferrell LD: Best practices in diagnostic immunohistochemistry: hepatocellular carcinoma versus metastatic neoplasms. Arch Pathol Lab Med. 2007, 131: 1648-1654.","journal-title":"Arch Pathol Lab Med"},{"key":"620_CR8","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1053\/hupa.2002.130104","volume":"33","author":"SK Lau","year":"2002","unstructured":"Lau SK, Prakash S, Geller SA, Alsabeh R: Comparative immunohistochemical profile of hepatocellular carcinoma, cholangiocarcinoma,and metastatic adenocarcinoma. Hum Patho. 2002, 33: 1175-1181. 10.1053\/hupa.2002.130104.","journal-title":"Hum Patho"},{"key":"620_CR9","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1097\/00000478-200208000-00002","volume":"26","author":"PG Chu","year":"2002","unstructured":"Chu PG, Ishizawa S, Wu E, Weiss LM: Hepatocyte antigen as a marker of hepatocellular carcinoma: an immunohistochemical comparison to carcinoembryonic antigen, CD10, and alpha-fetoprotein. Am J Surg Pathol. 2002, 26: 978-988. 10.1097\/00000478-200208000-00002.","journal-title":"Am J Surg Pathol"},{"key":"620_CR10","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1309\/8L872RPHEJRKF5JJ","volume":"119","author":"S Kakar","year":"2003","unstructured":"Kakar S, Muir T, Murphy LM, Lloyd RV, Burgart LJ: Immunoreactivity of Hep Par 1 in hepatic and extrahepatic tumors and its correlation with albumin in situ hybridization in hepatocellular carcinoma. Am J Clin Pathol. 2003, 119: 361-366. 10.1309\/8L872RPHEJRKF5JJ.","journal-title":"Am J Clin Pathol"},{"key":"620_CR11","first-page":"686","volume":"10","author":"MI Minervini","year":"1997","unstructured":"Minervini MI, Demetris AJ, Lee RG, Carr BI, Madariaga J, Nalesnik MA: Utilization of hepatocyte-specific antibody in the immunocytochemical evaluation of liver tumors. Mod Pathol. 1997, 10: 686-692.","journal-title":"Mod Pathol"},{"key":"620_CR12","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1159\/000325951","volume":"50","author":"L Wang","year":"2006","unstructured":"Wang L, Vuolo M, Suhrland MJ, Schlesinger K: HepPar1, MOC-, pCEA, mCEA and CD10 for distinguishing hepatocellular carcinoma vs. metastatic adenocarcinoma in liver fine needle aspirates. Acta Cytol. 2006, 50: 257-262. 10.1159\/000325951.","journal-title":"Acta Cytol"},{"key":"620_CR13","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1097\/01.MP.0000052103.13730.20","volume":"16","author":"Z Fan","year":"2003","unstructured":"Fan Z, van de Rijn M, Montgomery K, Rouse RV: Hep par 1 antibody stain for the differential diagnosis of hepatocellular carcinoma: 676 tumors tested using tissue microarrays and conventional tissue sections. Mod Pathol. 2003, 16: 137-144. 10.1097\/01.MP.0000052103.13730.20.","journal-title":"Mod Pathol"},{"key":"620_CR14","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1046\/j.1365-2559.1998.00522.x","volume":"33","author":"AS Leong","year":"1998","unstructured":"Leong AS, Sormunen RT, Tsui WM, Liew CT: Hep Par 1 and selected antibodies in the immunohistological distinction of hepatocellular carcinoma from cholangiocarcinoma, combined tumours and metastatic carcinoma. Histopathology. 1998, 33: 318-324. 10.1046\/j.1365-2559.1998.00522.x.","journal-title":"Histopathology"},{"key":"620_CR15","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1038\/modpathol.2008.37","volume":"21","author":"S Aviel-Ronen","year":"2008","unstructured":"Aviel-Ronen S, Lau SK, Pintilie M, Lau D, Liu N, Tsao MS, Jothy S: Glypican-3 is overexpressed in lung squamous cell carcinoma, but not in adenocarcinoma. Mod Pathol. 2008, 21: 817-825. 10.1038\/modpathol.2008.37.","journal-title":"Mod Pathol"},{"key":"620_CR16","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1309\/8DN7DQRDFB4QNH3N","volume":"130","author":"DL Zynger","year":"2008","unstructured":"Zynger DL, Everton MJ, Dimov ND, Chou PM, Yang XJ: Expression of glypican 3 in ovarian and extragonadal germ cell tumors. Am J Clin Pathol. 2008, 130: 224-230. 10.1309\/8DN7DQRDFB4QNH3N.","journal-title":"Am J Clin Pathol"},{"key":"620_CR17","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1111\/j.1365-2559.2006.02522.x","volume":"49","author":"M Hishinuma","year":"2006","unstructured":"Hishinuma M, Ohashi KI, Yamauchi N, Kashima T, Uozaki H, Ota S, Kodama T, Aburatani H, Fukayama M: Hepatocellular oncofetal protein, glypican 3 is a sensitive marker for alpha-fetoprotein- producing gastric carcinoma. Histopathology. 2006, 49: 479-486. 10.1111\/j.1365-2559.2006.02522.x.","journal-title":"Histopathology"},{"issue":"5","key":"620_CR18","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.acthis.2011.09.002","volume":"114","author":"S Choi","year":"2012","unstructured":"Choi S, Park C, Ahn M, Lee JH, Shin T: Immunohistochemical study of arginase 1 and 2 in various tissues of rats. Acta Histochem. 2012, 114 (5): 487-494. 10.1016\/j.acthis.2011.09.002.","journal-title":"Acta Histochem"},{"key":"620_CR19","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/BF00496818","volume":"87","author":"H Multhaupt","year":"1987","unstructured":"Multhaupt H, Fritz P, Schumacher K: Immunohistochemical localisation of arginase in human liver using monoclonal antibodies against human liver arginase. Histochemistry. 1987, 87: 465-470. 10.1007\/BF00496818.","journal-title":"Histochemistry"},{"key":"620_CR20","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1002\/path.2606","volume":"219","author":"S Sekine","year":"2009","unstructured":"Sekine S, Ogawa R, Mcmanus MT, Kanai Y, Hebrok M: Dicer is required for proper liver zonation. J Pathol. 2009, 219: 365-372. 10.1002\/path.2606.","journal-title":"J Pathol"},{"key":"620_CR21","first-page":"205","volume-title":"WHO Classification of Tumors of the Digestive System","author":"ND Theise","year":"2010","unstructured":"Theise ND, Curado MP, Franceschi S: Hepatocellular carcinoma. WHO Classification of Tumors of the Digestive System. Edited by: Bosman FT, Carneiro F, Hruban RH, Theise ND. 2010, IARC Press, Lyon, France, 205-216. 4","edition":"4"},{"issue":"2","key":"620_CR22","first-page":"87","volume":"28","author":"MS Shiran","year":"2006","unstructured":"Shiran MS, Isa MR, Sherina MS, Rampal L, Hairuszah I, Sabariah AR: The utility of hepatocyte paraffin 1 antibody in the immunohistological distinction of hepatocellular carcinoma from cholangiocarcinoma and metastatic carcinoma. Malays J Pathol. 2006, 28 (2): 87-92.","journal-title":"Malays J Pathol"},{"key":"620_CR23","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/1746-1596-7-86","volume":"7","author":"S Haj\u00f3si-Kalcakosz","year":"2012","unstructured":"Haj\u00f3si-Kalcakosz S, Dezs\u0151 K, Bugyik E, B\u00f6d\u00f6r C, Paku S, P\u00e1vai Z, Hal\u00e1sz J, Schlachter K, Schaff Z, Nagy P: Enhancer of zeste homologue 2 (EZH2) is a reliable immunohistochemical marker to differentiate malignant and benign hepatic tumors. Diagn Pathol. 2012, 7: 86-10.1186\/1746-1596-7-86.","journal-title":"Diagn Pathol"},{"key":"620_CR24","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1746-1596-6-15","volume":"6","author":"H Hong","year":"2011","unstructured":"Hong H, Patonay B, Finley J: Unusual reticulin staining pattern in well-differentiated hepatocellular carcinoma. Diagn Pathol. 2011, 6: 15-10.1186\/1746-1596-6-15.","journal-title":"Diagn Pathol"},{"issue":"2","key":"620_CR25","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1309\/AJCPK1ZC9WNHCCMU","volume":"138","author":"DT Timek","year":"2012","unstructured":"Timek DT, Shi J, Liu H, Lin F: Arginase-1, HepPar-1, and Glypican-3 Are the Most Effective Panel of Markers in Distinguishing Hepatocellular Carcinoma From Metastatic Tumor on Fine-Needle Aspiration Specimens. Am J Clin Pathol. 2012, 138 (2): 203-210. 10.1309\/AJCPK1ZC9WNHCCMU.","journal-title":"Am J Clin Pathol"},{"issue":"4","key":"620_CR26","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1002\/cncy.21184","volume":"120","author":"R McKnight","year":"2012","unstructured":"McKnight R, Nassar A, Cohen C, Siddiqui MT: Arginase-1: a novel immunohistochemical marker of hepatocellular differentiation in fine needle aspiration cytology. Cancer Cytopathol. 2012, 120 (4): 223-229. 10.1002\/cncy.21184.","journal-title":"Cancer Cytopathol"},{"issue":"3","key":"620_CR27","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1097\/MOG.0b013e3283457d43","volume":"27","author":"SL Taylor","year":"2011","unstructured":"Taylor SL, Haque S: Hepatobiliary pathology. Curr Opin Gastroenterol. 2011, 27 (3): 248-255. 10.1097\/MOG.0b013e3283457d43.","journal-title":"Curr Opin Gastroenterol"},{"key":"620_CR28","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/1746-1596-7-96","volume":"7","author":"X Guo","year":"2012","unstructured":"Guo X, Xiong L, Zou L, Sun T, Zhang J, Li H, Peng R, Zhao J: L1 cell adhesion molecule overexpression in hepatocellular carcinoma associates with advanced tumor progression and poor patient survival. Diagn Pathol. 2012, 7: 96-10.1186\/1746-1596-7-96.","journal-title":"Diagn Pathol"},{"key":"620_CR29","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/1746-1596-7-44","volume":"7","author":"X Guo","year":"2012","unstructured":"Guo X, Xiong L, Sun T, Peng R, Zou L, Zhu H, Zhang J, Li H, Zhao J: Expression features of SOX9 associate with tumor progression and poor prognosis of hepatocellular carcinoma. Diagn Pathol. 2012, 7: 44-10.1186\/1746-1596-7-44.","journal-title":"Diagn Pathol"},{"key":"620_CR30","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/1746-1596-6-121","volume":"6","author":"H Schmilovitz-Weiss","year":"2011","unstructured":"Schmilovitz-Weiss H, Tobar A, Halpern M, Levy I, Shabtai E, Ben-Ari Z: Tissue expression of squamous cellular carcinoma antigen and Ki67 in hepatocellular carcinoma-correlation with prognosis: a historical prospective study. Diagn Pathol. 2011, 6: 121-10.1186\/1746-1596-6-121.","journal-title":"Diagn Pathol"},{"issue":"6","key":"620_CR31","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1309\/A09ERYMFR64NERDW","volume":"121","author":"PG Chu","year":"2004","unstructured":"Chu PG, Weiss LM: Immunohistochemical characterization of signet-ring cell carcinomas of the stomach, breast, and colon. Am J Clin Pathol. 2004, 121 (6): 884-892. 10.1309\/A09ERYMFR64NERDW.","journal-title":"Am J Clin Pathol"},{"issue":"4","key":"620_CR32","first-page":"1050","volume":"143","author":"AE Wennerberg","year":"1993","unstructured":"Wennerberg AE, Nalesnik MA, Coleman WB: Hepatocyte paraffin 1: a monoclonal antibody that reacts with hepatocytes and can be used for differential diagnosis of hepatic tumors. Am J Pathol. 1993, 143 (4): 1050-1054.","journal-title":"Am J Pathol"},{"issue":"6","key":"620_CR33","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.3892\/ol.2011.405","volume":"2","author":"H Iida","year":"2011","unstructured":"Iida H, Hata M, Kakuno A, Hirano H, Yamanegi K, Yamada N, Ohyama H, Terada N, Yasui C, Yamanaka N, Nakasho K: Expression of hepatocyte markers in mass-forming peripheral and periductal-infiltrating hilar intrahepatic cholangiocarcinomas. Oncol Lett. 2011, 2 (6): 1041-1046.","journal-title":"Oncol Lett"},{"issue":"12","key":"620_CR34","doi-asserted-by":"publisher","first-page":"2886","DOI":"10.1002\/ijc.24265","volume":"124","author":"W Cao","year":"2009","unstructured":"Cao W, Sun B, Feitelson MA, Wu T, Tur-Kaspa R, Fan Q: Hepatitis C virus targets over-expression of arginase I in hepatocarcinogenesis. Int J Cancer. 2009, 124 (12): 2886-2892. 10.1002\/ijc.24265.","journal-title":"Int J Cancer"}],"container-title":["Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1746-1596-7-149.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1746-1596-7-149\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1746-1596-7-149.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,30]],"date-time":"2022-01-30T19:03:35Z","timestamp":1643569415000},"score":1,"resource":{"primary":{"URL":"https:\/\/diagnosticpathology.biomedcentral.com\/articles\/10.1186\/1746-1596-7-149"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,30]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["620"],"URL":"https:\/\/doi.org\/10.1186\/1746-1596-7-149","relation":{},"ISSN":["1746-1596"],"issn-type":[{"value":"1746-1596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10,30]]},"article-number":"149"}}